Hosted on MSN1mon
Goldman Sachs Initiates Coverage of Silence Therapeutics plc - Depositary Receipt () (SLN) with Sell Recommendation
F intel reports that on February 11, 2025, Goldman Sachs initiated coverage of Silence Therapeutics plc - Depositary Receipt (NasdaqGM:SLN) with a Sell recommendation. Analyst Price Forecast ...
Yahoo Finance10d
Revenue Downgrade: Here's What Analysts Forecast For Silence Therapeutics plc (NASDAQ:SLN)
Today is shaping up negative for Silence Therapeutics plc (NASDAQ:SLN) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. There was a fairly ...